Celiprolol (Celol): Discontinuation
Mylan has informed PHARMAC of the discontinuation of Celol tab 200 mg (Pharmacode 2031337).
Mylan’s Celol is the only brand of celiprolol that is currently registered with Medsafe. This means that celiprolol is expected to be delisted from the Pharmaceutical Schedule once current supply runs out. Celol will be delisted on 1 April 2021. This allows time for stock in the supply chain to be dispensed and claimed before delisting.
Patients taking celiprolol will need to talk to their health care professional about switching to alternative treatments.
Celiprolol is a beta adrenoceptor blocker. We recognise that changing patient’s medicines can be difficult and apologise for the inconvenience.